Business news
The latest business news from across the chemistry-using industries, including mergers and acquisitions, legal and patent disputes, regulation and commercial performance, from the Royal Society of Chemistry's magazine, Chemistry World
-
OpinionGiving companies room to grow
Can shopping centres and offices become urban lab spaces for innovative companies to grow and scale-up?
-
BusinessOut of the suburbs: the rise of urban labs
Could empty office blocks and shopping centres provide much-needed space for growing companies?
-
BusinessThe problem of scale-up in the UK
What’s the point of knowledge generation if we’re not creating high value jobs, asks Chris Kay
-
BusinessThe hole in the UK chemical industry
Norman Keane thinks ICI’s breakup has left a gap in scale-up knowhow and skills, as well as a lack of facilites
-
BusinessAcceptable levels of (epi)genetic engineering
Amplifying or silencing genes may be preferable to permanently changing genetic code
-
Business29 dead in explosions at two illegal fireworks factories in India
Incidents in Gujarat and West Bengal highlight minimal oversight of hazardous industry
-
BusinessBioLab fined for fire and chemical plume at US plant
‘Improperly stored’ pool chemicals reacted with water to release chlorine
-
BusinessGovernment reduces UK Reach fees by ‘£40 million’
Registration fees for most chemicals reduced, but uncertainty remains over safety data requirements
-
BusinessEpigenetic editors enter clinical trials
New wave of precision medicines amplify or silence genes, without altering genetic code
-
OpinionTrump’s tariff stand-off
Piling cost and complexity to stretched global supply chains will hit industries hard
-
BusinessTrump’s new tariffs threaten the chemicals sector
Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries
-
BusinessJ&J’s third talc bankruptcy settlement attempt denied
Company says it will return to courts to fight talc cancer claims
-
BusinessUS regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
-
-
OpinionWelcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…
-
BusinessBayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
-
OpinionGetting into the weeds of the glyphosate debate
Assessments of the risk posed by the controversial herbicide depend on how the evidence is weighed
-
BusinessUS reviews chemical incident prevention planning rules
Risk Management Program has been extended and rolled back under successive governments
-
OpinionWeight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
-
BusinessUS drops chloroprene emissions lawsuit against Denka
Government says lawsuit stretched legal definitions in pursuit of ‘environmental justice’